🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsTRIUMPH program trial design overview — all Phase 3 arms Page 14

TRIUMPH program trial design overview — all Phase 3 arms

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 324 replies 45,778 viewsPage 14 of 20
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Aug 17, 2024 at 6:50 AM#66

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. No action needed from anybody.

Last edited: Aug 17, 2024 at 8:50 AM
22 22PharmHunterJen, TomTeleRx, DoseLogDan and 19 others
Reply Quote Save Share Report
AussieAnna
Member
678
2,890
Jun 2024
Sydney, AU
Aug 20, 2024 at 6:21 PM#67

Old thread, but it comes up first when you search for this, so it is worth updating. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

Last edited: Aug 20, 2024 at 7:21 PM
21 21HPLC_Greg, LibrarianMeg, bri_stats and 18 others
Reply Quote Save Share Report
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Aug 24, 2024 at 5:50 AM#68

Clinical perspective, offered as context rather than as advice. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

That is the short version; the long version is somebody else's post.

Last edited: Aug 24, 2024 at 10:50 AM
20 20robert_kc, dan_philly, MeganSA_TX and 17 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Aug 27, 2024 at 5:17 PM#69
PharmD_Rodriguez said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Same pattern here, and in the same order.

19 19Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 16 others
Reply Quote Save Share Report
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Aug 31, 2024 at 4:42 AM#70
PharmD_Rodriguez said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

There is a second half to this that has not been said yet. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

47 22kate.chem, DataDave, Dr.GutHealth and 44 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register